Discovery

Target identification is an essential first step toward the discovery and development of any new therapeutic. It therefore becomes crucial to perform due diligence around a target of interest before embarking on the long, time-consuming, expensive and high-risk endeavour of drug development.

Excelra offers a custom service in providing a comprehensive target assessment dossier for global biotech and pharma companies. The dossier is a compendium of information on the complete target profile including structural, systemic and functional aspects of a protein and the gene-encoding it. By providing a 360-degree view of a target we help facilitate critical Go/No-go decision making.

Decades of burgeoning advances in pharmacology and medicinal chemistry have left in their wake, enormous amounts of diverse and valuable data on biologically active small molecules and compounds.

Driven by our proven techno-manual data curation capabilities, Excelra delivers comprehensive chemistry content management services to global scientific content providers, as well as biotech and pharma organizations. Our talented and scalable scientific teams excerpt, enhance, and enrich big chemistry data from various sources, providing practical solutions to challenges in drug discovery.